Global Health Limited

NSEI:MEDANTA Rapport sur les actions

Capitalisation boursière : ₹299.1b

Global Health Croissance future

Future contrôle des critères 4/6

Global Health devrait augmenter ses bénéfices et son chiffre d'affaires de 20.2% et de 14.6% par an respectivement. Le BPA devrait croître de de 19.5% par an. Le rendement des capitaux propres devrait être 17.4% dans 3 ans.

Informations clés

20.2%

Taux de croissance des bénéfices

19.5%

Taux de croissance du BPA

Healthcare croissance des bénéfices27.3%
Taux de croissance des recettes14.6%
Rendement futur des capitaux propres17.4%
Couverture par les analystes

Good

Dernière mise à jour18 Nov 2024

Mises à jour récentes de la croissance future

Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 22
Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

The Return Trends At Global Health (NSE:MEDANTA) Look Promising

Sep 01
The Return Trends At Global Health (NSE:MEDANTA) Look Promising

With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Aug 02
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

We Think Global Health (NSE:MEDANTA) Can Manage Its Debt With Ease

Jul 15
We Think Global Health (NSE:MEDANTA) Can Manage Its Debt With Ease

Global Health Limited's (NSE:MEDANTA) Share Price Matching Investor Opinion

May 22
Global Health Limited's (NSE:MEDANTA) Share Price Matching Investor Opinion

Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 22
Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Returns On Capital Are Showing Encouraging Signs At Global Health (NSE:MEDANTA)

May 04
Returns On Capital Are Showing Encouraging Signs At Global Health (NSE:MEDANTA)

Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?

Apr 12
Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?

Is Global Health (NSE:MEDANTA) A Risky Investment?

Mar 22
Is Global Health (NSE:MEDANTA) A Risky Investment?

Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher

Feb 13
Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher

There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital

Jan 18
There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital

With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Dec 26
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jun 01
Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors

Mar 30
Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors

Prévisions de croissance des bénéfices et des revenus

NSEI:MEDANTA - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/202749,3917,8575,83310,07711
3/31/202643,2086,4503,8128,72812
3/31/202536,9965,1162,0047,06512
9/30/202434,6274,8821,9156,288N/A
6/30/202433,5664,825N/AN/AN/A
3/31/202432,7514,7823,3356,121N/A
12/31/202331,6604,519N/AN/AN/A
9/30/202330,2774,0894,0246,400N/A
6/30/202328,4983,694N/AN/AN/A
3/31/202327,0993,2614,0856,445N/A
12/31/202225,1642,426N/AN/AN/A
6/30/202223,0432,1321,1093,724N/A
3/31/202221,7251,9623683,113N/A
3/31/202114,5192889602,418N/A
3/31/202015,182363-1321,751N/A
3/31/201914,782610-1,4961,501N/A
3/31/201813,677329N/AN/AN/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de MEDANTA ( 20.2% par an) est supérieure au taux d'épargne ( 6.7% ).

Bénéfices vs marché: Les bénéfices de MEDANTA ( 20.2% par an) devraient croître plus rapidement que le marché Indian ( 18% par an).

Croissance élevée des bénéfices: Les bénéfices de MEDANTA devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de MEDANTA ( 14.6% par an) devrait croître plus rapidement que le marché Indian ( 10.5% par an).

Croissance élevée des revenus: Le chiffre d'affaires de MEDANTA ( 14.6% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de MEDANTA devrait être faible dans 3 ans ( 17.4 %).


Découvrir les entreprises en croissance